Feedback / Questions
abelacimab (MAA868) - Anthos Therap
https://www.businesswire.com/news/home/20250210114240/en/Blackstone-Life-Sciences-and-Anthos-Therapeutics-Announce-Agreement-for-Anthos-to-be-Acquired-by-Novartis-for-up-to-3.1-Billion
Feb 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next